De novo cancer may double the risk for long-term mortality among solid organ transplantation recipients, a population-based study shows.
A treat-to-target approach appears feasible in patients with elderly-onset rheumatoid arthritis, with similar disease control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results